Grosicki GJ, Thomas JG, Dhurandhar NV, Lofton H, et al. Glucagon-like peptide-1 receptor agonists discontinuation is higher in individuals with overweight and obesity without type 2 diabetes. Diabetes Obes Metab 2025 Jan 2. doi: 10.1111/dom.16151.
PMID: 39743934